The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.
Cardiac Fibrosis: The Fibroblast Awakens
Open accessAbstract
Myocardial fibrosis is a significant global health problem associated with nearly all forms of heart disease. Cardiac fibroblasts comprise an essential cell type in the heart that is responsible for the homeostasis of the extracellular matrix; however, upon injury, these cells transform to a myofibroblast phenotype and contribute to cardiac fibrosis. This remodeling involves pathological changes that include chamber dilation, cardiomyocyte hypertrophy and apoptosis, and ultimately leads to the progression to heart failure. Despite the critical importance of fibrosis in cardiovascular disease, our limited understanding of the cardiac fibroblast impedes the development of potential therapies that effectively target this cell type and its pathological contribution to disease progression. This review summarizes current knowledge regarding the origins and roles of fibroblasts, mediators and signaling pathways known to influence fibroblast function after myocardial injury, as well as novel therapeutic strategies under investigation to attenuate cardiac fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cardiac diseases involve pathological fibrotic remodeling caused by CF proliferation and ECM deposition53.”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [53]
In the citing paper
“Focal cardiac fibrosis that arises post-MI is a major clinical burden that often leads to a cascade of pathological remodeling and may result in heart failure53.”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [53]
In the citing paper
“CFs themselves cannot generate action potentials”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [53]
In the citing paper
“excessive ECM production reduces cardiomyocyte-cardiomyocyte (CM) connectivity, leading to reduced tissue compliance and electrical synchronization53.”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
D’Souza, K. M., Malhotra, R., Philip, J. L., Staron, M. L., Theccanat, T., Jeevanandam, V., & Akhter, S. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a111.218263 · Cited by 31
RetractedGurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J., Antos, C. L., Markham, B. E., Richardson, J. A., Robbins, J. M., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationDirect reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A. K., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,251
Cited by
Sorted by citations
Items 901–999 of 999
Cardiac Fibroblasts Play Pathogenic Roles in Idiopathic Restrictive Cardiomyopathy
Tsuru, H., Ishida, H., Narita, J., Ishii, R., Suginobe, H., Ishii, Y., Wang, R., Kogaki, S., Taira, M., Ueno, T., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1008 · Cited by 11
Monroe, T. B., & Anderson, E. J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00262 · Cited by 12
Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice
Pan, X., Chen, X., Ren, Q., Yue, L., Niu, S., Li, Z., Zhu, R., Chen, X., Jia, Z., Zhen, R., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.034 · Cited by 11
The complicated lives of GPCRs in cardiac fibroblasts
Mazarura, G. R., Dallagnol, J. C. C., Chatenet, D., Allen, B. G., & Hébert, T. E. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00120.2022 · Cited by 12
Liu, B., Liu, N., Liu, W., Zhang, S., Zhang, J., Li, A., & Liu, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.095 · Cited by 11
Gao, T. A., & Chen, Y. Y. (2022) · Science · doi:10.1126/science.abn0851 · Cited by 11
Merce, A.-G., Nisulescu, D. D., Hermenean, A. O., Burciu, O. M., Munteanu, I.-R., Merce, A.-P., Brie, D. M., & Mornoş, C. (2026) · Metabolites · doi:10.3390/metabo16010059 · Cited by 12
Karkampouna, S., van der Helm, D., Scarpa, M., van Hoek, B., Verspaget, H. W., Goumans, M., Coenraad, M. J., Kruithof, B. P. T., & Julio, M. K. (2021) · Cells · doi:10.3390/cells10123325 · Cited by 10
Leancă, S. A., Afrăsânie, I., Crișu, D., Matei, I. T., Duca, Ș.-T., Costache, A. D., Aursulesei, V. O., Tudorancea, I., Mitu, O., Bădescu, M. C., et al. (2023) · Life · doi:10.3390/life13041000 · Cited by 13
Obstructive Sleep Apnea and Hypertensive Heart Disease: From Pathophysiology to Therapeutics
Liu, L., Wang, Y., Hong, L., Bragazzi, N. L., Dai, H., & Chen, H. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412342 · Cited by 11
Delaunay, M., Paterek, A., Gautschi, I., Scherler, G., & Diviani, D. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119674 · Cited by 11
Guo, M. L., Yu, J., Long, X., Liu, W., Aris, A. Z., Yang, D., Luo, Y., Xu, Y., & Yu, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116110 · Cited by 10
The Role of Speckle Tracking Echocardiography in the Evaluation of Advanced-Heart-Failure Patients
Martini, L., Lisi, M., Pastore, M. C., Righini, F. M., Rubboli, A., Henein, M. Y., & Cameli, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144037 · Cited by 10
Mahmoud, M. M., El‐Batran, S., Hegazy, R. R., & El-Sayed, W. M. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4682 · Cited by 10
Martin, E. M., Chang, J., González, A., & Genovese, F. (2025) · Matrix Biology · doi:10.1016/j.matbio.2025.03.001 · Cited by 9
Xie, Y., Liang, B., Meng, Z., Guo, R., Liu, C., Yuan, Y., Mu, W., Wang, Y., & Cao, J.-M. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-09982-6 · Cited by 10
Li, Q., Ren, C., Jiang, B., Wang, X., Wang, C., Zhi, X., Li, L., Guo, X., Zhao, X., & Li, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1554696 · Cited by 11
Zhang, S., Li, S., Li, X., Wan, C., Cui, L., & Wang, Y. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2488994 · Cited by 10
Pluripotent stem cell-based approaches for heart repair and the potential of genetic modifications
Dulak, J., Zieliński, T., Józkowicz, A., & Łoboda, A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.07.009 · Cited by 12
EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A
Yi, H., Liu, C., Shi, J., Wang, S., Zhang, H., He, Y., Tao, J., Li, S., & Zhang, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.869279 · Cited by 10
Sacubitril/valsartan in Heart Failure and Beyond—From Molecular Mechanisms to Clinical Relevance
Muric, M. D., Srejovic, I. M., Joksimović, J., Sretenovic, J. Z., Jeremic, J. N., Čekerevac, I., Simovic, S. M., Djoković, D., Muric, N. N., Stojić, V., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2307238 · Cited by 11
Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure
Gehris, J., Ervin, C., Hawkins, C., Womack, S. J., Churillo, A. M., Doyle, J., Sinusas, A. J., & Spinale, F. G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115914 · Cited by 11
Delgado‐Arija, M., Genovés, P., Pérez-Carrillo, L., González-Torrent, I., Giménez-Escamilla, I., Martínez‐Dolz, L., Portolés, M., Tarazón, E., & Roselló‐Lletí, E. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04900-w · Cited by 11
Wei, J., Wang, D., Cui, C., Tan, J., Peng, M., & Lu, H. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1237 · Cited by 10
Application of Bioengineered Materials in the Surgical Management of Heart Failure
Pattar, S. S., Hassanabad, A. F., & Fedak, P. W. M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00123 · Cited by 10
Tugging at the Heart Strings: The Septin Cytoskeleton in Heart Development and Disease
Moore, K. S., Moore, R. A., Wang, C. E., & Norris, R. A. (2020) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd7010003 · Cited by 10
Xu, H., Yang, Z., Zhang, Y., Peng, W., Xia, C., Li, Z., He, Y., Xu, R., Rao, L., Peng, Y., et al. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01313-2 · Cited by 10
RetractedGiridharan, V. V., Karuppagounder, V., Arumugam, S., Nakamura, Y., Guha, A., Barichello, T., Quevedo, J., Watanabe, K., Konishi, T., & Thandavarayan, R. A. (2020) · Cells · doi:10.3390/cells9030597 · Cited by 10
A Large Mammalian Model of Myocardial Regeneration After Myocardial Infarction in Fetal Sheep
Hodges, M. M., Zgheib, C., & Liechty, K. W. (2020) · Advances in Wound Care · doi:10.1089/wound.2018.0894 · Cited by 10
Kastner, N., Zlabinger, K., Spannbauer, A., Traxler, D., Mester-Tonczar, J., Hašimbegović, E., & Gyöngyösi, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01314 · Cited by 10
Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
Navarrete, C. M., García‐Martín, A., DeMesa, J., & Muñóz, E. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01112-7 · Cited by 10
Sullivan, R., Randhawa, V. K., Lalonde, T. J., Yu, T., Kiaii, B. B., Luyt, L. G., Wisenberg, G., & Dhanvantari, S. (2020) · CJC Open · doi:10.1016/j.cjco.2020.10.015 · Cited by 10
Koga, M., Karim, M. R., Kuramochi, M., Izawa, T., Kuwamura, M., & Yamate, J. (2021) · Toxicologic Pathology · doi:10.1177/0192623320982526 · Cited by 10
Luu, A. Z., Luu, V. Z., Chowdhury, B., Kosmopoulos, A., Pan, Y., Al-Omran, M. A., Quan, A., Teoh, H., Hess, D. A., & Verma, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100926 · Cited by 10
AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing
Song, Y., Zhang, Y., Zhang, X., Hu, S., Wang, J., Deng, G., & Zhou, Z. (2022) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2022.2119667 · Cited by 10
González, A., López, B., Ravassa, S., José, G. S., & Dı́ez, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.07.016 · Cited by 9
Invited Commentary: The Hunt for Mechanistic Origins of Liver Fibrosis in the Fontan Circulation
Rychik, J. R., & Goldmuntz, E. (2021) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/2150135121989974 · Cited by 10
Xu, R., Ding, Z., Li, H., Shi, J., Cheng, L., Xu, H., Wu, J., & Zou, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1071249 · Cited by 9
Myocardial fibrosis in rheumatic heart disease: emerging concepts and clinical implications
Putra, T. M. H., Rodríguez-Fernández, R., Widodo, W. A., Elfiana, M., Laksono, S., Nguyen, Q. N., Tan, J. W. C., & Narula, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1230894 · Cited by 9
Takano, A. P. C., de André, C. D. S., de Almeida, R., Waked, D., Veras, M. M., & Saldiva, P. H. N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118380 · Cited by 9
Are Endomyocardial Ventricular Biopsies Useful for Assessing Myocardial Fibrosis?
Makarov, I. A., Voronkina, D., Гурщенков, А. В., Рыжков, А. В., Starshinova, A. A., Kudlay, D. A., & Mitrofanova, L. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113275 · Cited by 9
Xiao, F., Li, H., Wang, J., Wu, H., Cai, Y., Wang, J., Che, H., Li, G., Xia, Z., Xie, Y., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02146-5 · Cited by 12
Li, X., Li, D., Liu, S., Wang, Y., Fan, X., Yan, Z., Tan, S., Zhuang, P., & Zhang, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157529 · Cited by 10
Heart failure: mechanistic insights and precision therapeutic strategies
Zhang, F., Zhang, X., Jian, J., Zeng, X., Zheng, C., Zhang, Y., & Gao, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1696793 · Cited by 10
State of change: epigenetic and mitochondrial regulation of cardiac fibroblast activation
Garvin, A. M., & Hale, T. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100557 · Cited by 9
Inappropriate Activation of TLR4/NF-κB is a Cause of Heart Failure
Zhou, J., Lin, H., Lv, T., Hao, J., Zhang, H., Sun, S., Yang, J., Chi, J., & Guo, H. (2022) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2022.0020 · Cited by 9
Induction of Senescence by Loss of Gata4 in Cardiac Fibroblasts
Zhang, Z., Shayani, G., Xu, Y., Kim, A., Hong, Y., Feng, H., & Zhu, H. (2023) · Cells · doi:10.3390/cells12121652 · Cited by 10
Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models
Bao, J., Gao, Z., Hu, Y., Ye, L., & Wang, L. (2023) · Channels · doi:10.1080/19336950.2023.2281743 · Cited by 9
Chen, Y.-W., Cheng, P., Yin, Y., Cai, H., Chen, J.-Z., Feng, M., Guo, W., Zhao, P., Zhang, C., Shan, X., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149360 · Cited by 9
Defining Transcriptomic Heterogeneity between Left and Right Ventricle-Derived Cardiac Fibroblasts
Dewar, M. B., Ehsan, F., Izumi, A., Zhang, H., Zhou, Y., Shah, H., Langburt, D., Suresh, H., Wang, T., Hacker, A., et al. (2024) · Cells · doi:10.3390/cells13040327 · Cited by 11
Mechanical stimulation of induced pluripotent stem cell derived cardiac fibroblasts
Bekedam, F. T., Smal, R., Smit, M. C., Aman, J., Noordegraaf, A. V., Bogaard, H. J., Goumans, M., de Man, F. S., & Valldeperas, A. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-60102-w · Cited by 11
Guo, S., Qi, X., Zhang, L., Lu, K., Li, X., Zhu, J., & Feng, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114086 · Cited by 10
Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases
Abolfazli, S., Karav, S., Johnston, T. P., & Sahebkar, A. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00694-w · Cited by 9
Xiao, L., Gu, Y., Gao, L., Shangguan, J., Chen, Y., Zhang, Y., & Li, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7288 · Cited by 9
Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts
Landry, N. M., Kavosh, M., Filomeno, K. L., Rattan, S. G., Czubryt, M. P., & Dixon, I. (2018) · Physiological Reports · doi:10.14814/phy2.13897 · Cited by 9
Hoang, T. T., Manso, P. H., Edman, S., Mercer‐Rosa, L., Mitchell, L. E., Sewda, A., Swartz, M. D., Fogel, M. A., Agopian, A. J., & Goldmuntz, E. (2019) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-019-0555-2 · Cited by 9
Direct Cardiac Reprogramming for Cardiovascular Regeneration and Differentiation
Sadahiro, T., & Ieda, M. (2020) · The Keio Journal of Medicine · doi:10.2302/kjm.2019-0008-oa · Cited by 9
Nudelman, V., Zahalka, M. A., Nudelman, A., Rephaeli, A., & Kessler‐Icekson, G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173255 · Cited by 9
Sung, P., Lin, K., Chai, H., Chiang, J. Y., Shao, P., Luo, C., & Yip, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176219 · Cited by 9
Wang, P., Zhang, W., Feng, Z., Zhang, J., Sun, Y. J., & Zhang, W. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12165 · Cited by 10
Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease
Halim, A., Narayanan, G., Hato, T., Ho, L., Wan, D., Siedlecki, A. M., Rhee, E. P., Allegretti, A. S., Nigwekar, S. U., Zehnder, D., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022991 · Cited by 9
Li, W., Jin, Q., Zhang, L., He, S., Song, Y., Xu, L., Deng, C., Wang, L., Qin, X., & Xie, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030729 · Cited by 9
Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
Li, M., Wang, P., Zou, Y., Wang, W., Zhao, Y., Liu, M., Wu, J., Zhang, Y., Zhang, N., & Sun, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15625 · Cited by 11
Hodges, M. M., Zgheib, C., Xu, J., Hu, J., Dewberry, L. C. K., Hilton, S. A., Allukian, M., Gorman, J. H., Gorman, R. C., & Liechty, K. W. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.12.042 · Cited by 9
Johnston, E. F., & Gillis, T. E. (2019) · Biology Open · doi:10.1242/bio.049296 · Cited by 9
Epigenetic Regulation of Heart Failure: Cell Type Matters
Padula, S. L., & Yutzey, K. E. (2021) · Circulation Research · doi:10.1161/circresaha.121.319642 · Cited by 9
Self-citationTrends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
Mao, Y., Fu, Q., Feng, S., Zhang, W., Zhong, Z., Zhou, Y., & Yang, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1182606 · Cited by 9
The role of TGF-β in cardiac fibrosis and heart failure: A review
Shah, G. B., & Prajapati, A. K. (2024) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2024.001 · Cited by 8
Martı́n-Puig, S., & Menendez-Montes, I. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_19 · Cited by 9
Du, H., Huangfu, W., Liu, Z., Jia, G., Zhao, F., & Cheng, W. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00122 · Cited by 8
Cell autonomous TLR4 signaling modulates TGF-β induced activation of human cardiac fibroblasts
Vijayakumar, G., Latha, A., Anil, A. P., Surve, Y., Aiswarya, R., Nair, B. G., & Pillai, I. C. L. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42452 · Cited by 8
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Wu, L., Zhu, L., & Chen, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70306 · Cited by 9
Kaur, R., Singh, S., Sood, P., Singh, S., Banerjee, S., & Singh, T. G. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10562-7 · Cited by 9
Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery
Moriwaki, T., Tani, H., & Tohyama, S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1687840 · Cited by 8
Desai, V. G., Azevedo‐Pouly, A. C. P., Vijay, V., Phanavanh, B., Moland, C. L., Han, T., Revollo, J. R., Aryal, B., Rao, V. A., & Fuscoe, J. C. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4405 · Cited by 8
Remes, A. K., Noormalal, M., Schmiedel, N., Frey, N., Frank, D., Müller, O. J., & Graf, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-30196-9 · Cited by 8
Niu, P., Tan, X., Zhou, X., Xu, X., Guannan, Z., Li, P., & Bai, M. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103157 · Cited by 8
Computational screen for sex-specific drug effects in a cardiac fibroblast signaling network model
Watts, K. M., Nichols, W., & Richardson, W. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-44440-9 · Cited by 8
Dai, H., Tao, S., Guan, Y., Zhang, Y., Yang, Z., Jia, J., Zhang, X., & Zhang, G. (2023) · International Heart Journal · doi:10.1536/ihj.23-265 · Cited by 8
Yang, Y., Guo, J., Liu, C., Nan, J., Wu, Y., & Jin, C. H. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400131 · Cited by 8
Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
Zhang, Y., Wei, S., Jin, E., Jo, Y., Oh, C., Bae, G., Kang, J., & Ryu, D. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0362 · Cited by 8
Pericardial Fluid Accumulates microRNAs That Regulate Heart Fibrosis after Myocardial Infarction
Silva, E. D., Pereira-Sousa, D., Ribeiro-Costa, F., Cerqueira, R. J., Enguita, F. J., Gomes, R. N., Dias-Ferreira, J., Pereira, C., Castanheira, A., Pinto‐do‐Ó, P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158329 · Cited by 8
Aging-associated mechanisms of atrial fibrillation progression and their therapeutic potential
Zhao, S., Johnston, A. M., Yiu, C. H. K., Moreira, L. M., Reilly, S. N., & Wehrens, X. H. T. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.12 · Cited by 9
The m7G methylation modification: An emerging player of cardiovascular diseases
Xu, C., Yu, X.-H., Wang, G., Luo, W., Chen, L., & Xia, X.-D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142940 · Cited by 8
Ooi, J. Y. Y., Bernardo, B. C., & McMullen, J. R. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.12.01 · Cited by 8
AdipoRs- a potential therapeutic target for fibrotic disorders
Ma, L., Li, X., Bai, Z., Lin, X., & Lin, K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1559823 · Cited by 9
Single-cell transcriptional profile of ACE2 in healthy and failing human hearts
Zhou, Y., Huang, Y., Song, X., Guo, X., Pang, J., Wang, J., Zhang, S., & Wang, C. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1787-5 · Cited by 8
Sarfaraz, S., Singh, S., Hawke, A., Clarke, S. T., & Ramdath, D. D. (2020) · Nutrients · doi:10.3390/nu12113404 · Cited by 8
Actin-granule formation is an additional step in cardiac myofibroblast differentiation
He, L., Liu, R., Yue, H., Ren, S., Zhu, G., Guo, Y., & Qin, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-8231 · Cited by 8
SAHA could inhibit TGF-β1/p38 pathway in MI-induced cardiac fibrosis through DUSP4 overexpression
Wang, K., Tang, R., Wang, S., Wang, W., Zhang, K., Li, J., Li, P., & Tang, Y. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01900-4 · Cited by 8
Shi, C., Li, X., Hong, F., Wang, X., Jiang, T., Sun, B., & Li, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10580 · Cited by 9
Rejuvenating the Aging Heart by Enhancing the Expression of the Cisd2 Prolongevity Gene
Yeh, C., Chou, Y.-J., Chu, T.-K., & Tsai, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111487 · Cited by 8
A prognostic fibroblast-related risk signature in colorectal cancer
Xu, H., & Pan, Y. (2021) · Aging · doi:10.18632/aging.203677 · Cited by 8
Liu, Y., Hu, J., Wang, W., & Wang, Q. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07312-w · Cited by 8
Knockdown of HIPK2 Attenuates Angiotensin II–Induced Cardiac Fibrosis in Cardiac Fibroblasts
Xu, F., Mao, B., Li, Y., & Zhao, Y. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001292 · Cited by 7
Cardiovascular consequences of sickle cell disease
Palomarez, A., Jha, M., Romero, X. M., & Horton, R. E. (2022) · Biophysics Reviews · doi:10.1063/5.0094650 · Cited by 10
Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts
Khan, S. M., Martin, R., Bayne, A. N., Pétrin, D., Bourque, K., Jones-Tabah, J., Bouazza, C. A., Blaney, J., Lau, J., Martins-Cannavino, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103064 · Cited by 8
Zhang, M., Xinzhou, W., Chen, W., Liu, W., Xin, J., Yang, D., Zhang, Z., & Zheng, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-36117-0 · Cited by 9
A bibliometric analysis of cardiomyocyte apoptosis from 2014 to 2023: A review
Wang, R., Luo, X. W., Li, S., Wen, X., Zhang, X., Zhou, Y., & Xie, W. (2023) · Medicine · doi:10.1097/md.0000000000035958 · Cited by 8
Metadata
- Authors
- Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Venue
- Circulation Research
- Published
- 2016-03-18
- Volume
- 118
- Issue
- 6
- Pages
- 1021-1040
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC4800485
- OpenAlex
- W2299099463
- Cited by
- 1,596
- References
- 261
- Citations by year
- 2026: 156 · 2025: 175 · 2024: 184 · 2023: 182 · 2022: 156 · 2021: 211 · 2020: 163 · 2019: 143 · 2018: 98 · 2017: 95 · 2016: 30
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL129772, R01HL091475, R01HL134312, R01HL132551, R01HL133695, U54HL119810)
- National Institute of General Medical Sciences (R01GM097347)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- myocardial fibrosis, cardiac fibroblasts, myofibroblast differentiation, extracellular matrix homeostasis, myocardial injury, cardiac remodeling, cardiomyocyte hypertrophy, cardiomyocyte apoptosis, heart failure, signaling pathways, treatment options
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Heart Failure, Humans, Cardiomyopathies, Inflammation Mediators, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review